Pro-Gastrin-Releasing Peptide (ProGRP) –A Diagnostic Biomarker for Small-Cell Lung Cancer
Main Author: | Petra STIEBER |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2009-03-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2009.03.19&path%5B%5D=240 |
Similar Items
-
Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response
by: Wojcik E, et al.
Published: (2017-11-01) -
Multicenter Evaluation of A New Progastrin-releasing Peptide (ProGRP) Immunoassay across Europe and China
by: Catharina M. KORSE, et al.
Published: (2017-08-01) -
Diagnostic Value of ProGRP and NSE for Small Cell Lung Cancer: a meta-analysis
by: Jiwen WANG, et al.
Published: (2010-12-01) -
A rare case of Ewing sarcoma with elevated plasma pro-gastrin-releasing peptide (proGRP) level
by: Yoshitane Tsukamoto, MD, PhD, et al.
Published: (2016-12-01) -
Utility of NSE, ProGRP and LDH in Diagnosis and Treatment
in Patients with Small Cell Lung Cancer
by: Yan PENG, et al.
Published: (2016-09-01)